• Startseite
  • Aktien
  • Arena Pharmaceuticals Aktie

    • Arena Pharmaceuticals

    49,195 $ -1,37% -0,685 $
    In : 43,375 € | 16:31:01 Uhr Nasdaq | Mehr Kurse »
    WKN: A2DR4A
    ISIN: US0400476075
    US-Symbol: ARNA
    Typ: Aktie
    • Push
    • Intraday
    • 5 Tage
    • 3 Monate
    • 1 Jahr
    • Gesamt
    Arena Pharmaceuticals Aktie Chart

    Performance Arena Pharmaceuticals Aktie

      
    1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
    Kurs 48,15 $ 43,17 $ 39,71 $ 38,95 $ 41,19 $ 16,10 $
    Änderung +2,17% +13,96% +23,89% +26,30% +19,43% +205,56%

    Nachrichten zur Arena Pharmaceuticals Aktie

      
    14:35 Arena Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference on February 27 PR Newswire
    20.02.19 Arena Pharmaceuticals to Announce Fourth Quarter and Full-Year 2018 Financial Results and Provide Corporate Update on February 26 PR Newswire
    07.02.19 Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn's & Colitis Congress PR Newswire
    24.01.19 United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag PR Newswire
    24.01.19 Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag PR Newswire
    07.01.19 Arena Pharmaceuticals Reports Positive Long-Term Data from the Open-​Label Extension of the Phase 2 OASIS Trial Evaluating Etrasimod for Treatment of Ulcerative Colitis PR Newswire

    Forum zur Arena Pharmaceuticals Aktie

      
    4
    ARNA - Arena Pharmaceuticals
    185 Beiträge
    Vassago: ARNA 43,56$
    25.01.19
    Lizenzdeal mit United Therapeutics abgeschlossenhttp://invest.arenapharm.com/news-​releases/news-​release-details/arena-​pharmaceuticals-announces-closing-global-license-agreement
     
    ARENA: show down am 14. September
    2 Beiträge
    Magnetfeldfre.: Arena die nächste Dendreon?
    02.09.10
    Der Showdown, genauer das Panel sind am 169.2010 und die FDA Entscheidung am 22.10.2010!

    Analysen

      
    Kaufen Halten Verkaufen
    Analysten 0 0 0
    Markt-Lotsen 0 0 0

    Aktie & Unternehmen

      
    Branche Pharmazie
    Herkunft USA
    Website www.arenapharm.com
    Indizes/Listen NASDAQ
    Aktienanzahl 49,2 Mio. (Stand: 25.06.18)
    Marktkap. 2,42 Mrd. $

    Dividenden

      
    Dividenden

    Ähnliche Aktien

      
    Name
    last
    change_rel
     
    Palatin Technologies 0,71 € -1,93%
    Albireo Pharma 22,23 € +0,50%
    Cannabis Science 0,038 € -11,63%
    Gilead Sciences 58,02 € -1,18%
    Johnson & Johnson 118,90 € -1,16%